Infusion Catheter Market Size Analysis and Top Companies
The global infusion catheter market size is estimated to hit around USD 5.10 billion by 2033, increasing from USD 1.88 billion in 2023 with a CAGR of 10.32% from 2023 to 2033. The top companies operating in the infusion catheter are Medtronic, B. Braun Melsungen AG, Terumo Corporation, Johnson & Johnson, Becton, Dickinson and Company, Teleflex Incorporated, Smiths Medical, Nipro Corporation, C.R. Bard (acquired by Becton, Dickinson and Company), AngioDynamics, Inc., Cook Medical, ICU Medical, Inc., Vygon SA, Fresenius Kabi AG, Merit Medical Systems, Inc., and Others.
Market Report Coverage
| Report Coverage |
Details |
| Growth Rate from 2024 to 2033 |
CAGR of 10.32% |
| Market Size in 2023 |
USD 1.88 Billion |
| Market Size by 2033 |
USD 5.10 Billion |
| Largest Market |
North America |
| Base Year |
2023 |
| Forecast Period |
2024 to 2033 |
| Segments Covered |
Type, Application, and Region |
| Regions Covered |
North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Infusion Catheter Key Players
- Medtronic
- B. Braun Melsungen AG
- Terumo Corporation
- Johnson & Johnson
- Becton, Dickinson and Company
- Teleflex Incorporated
- Smiths Medical
- Nipro Corporation
- C.R. Bard (acquired by Becton, Dickinson and Company)
- AngioDynamics, Inc.
- Cook Medical
- ICU Medical, Inc.
- Vygon SA
- Fresenius Kabi AG
- Merit Medical Systems, Inc.
Recent Developments
- In March 2021, Medtronic introduced the Chameleon Percutaneous Transluminal Angioplasty (PTA) balloon catheter in select European and African countries, including Germany, Portugal, Italy, South Africa, Turkey, and Spain. This innovative catheter is designed for use in a range of arterial applications, including femoral, iliac, and renal arteries, as well as both native and synthetic arteriovenous dialysis fistulas. The system's approval underscores its versatility and suitability for various vascular interventions, offering healthcare professionals a reliable and effective tool for angioplasty procedures. Medtronic's expansion of its product portfolio reflects ongoing efforts to address diverse clinical needs and enhance treatment options in the field of interventional cardiology and vascular care.
We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344
